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Background: Bone marrow is an accessible source of progenitor cells, which have been investigated as treatment
for neurological diseases in a number of clinical trials. Here we evaluated the potential benefit of bone marrow cells
in protecting against convulsive seizures induced by maximum electroconvulsive shock (MES), a widely used model
for screening of anti-epileptic drugs. Behavioral and inflammatory responses were measured after MES induction in
order to verify the effects promoted by transplantation of bone marrow cells. To assess the anticonvulsant effects of
bone marrow cell transplantation, we measured the frequency and duration of tonic seizure, the mortality rate, the
microglial expression and the blood levels of cytokine IL-1, IL-6, IL-10 and TNF-α after MES induction. We
hypothesized that these behavioral and inflammatory responses to a strong stimulus such as a convulsive seizure
could be modified by the transplantation of bone marrow cells.
Results: Bone marrow transplanted cells altered the convulsive threshold and showed anticonvulsant effect by
protecting from tonic seizures. Bone marrow cells modified the microglial expression in the analyzed brain areas,
increased the IL-10 and attenuate IL-6 levels.
Conclusions: Bone marrow cells exert protective effects by blocking the course of electroconvulsive seizures.
Additionally, electroconvulsive seizures induced acute inflammatory responses by altering the pattern of microglia
expression, as well as in IL-6 and IL-10 levels. Our findings also indicated that the anticonvulsant effects of these
cells can be tested with the MES model following the same paradigm used for drug testing in pharmacological
screening. Studies on the inflammatory reaction in response to acute seizures in the presence of transplanted bone
marrow cells might open a wide range of discussions on the mechanisms relevant to the pathophysiology of
epilepsies.
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Epilepsy represents a complex group of disorders in
which the main characteristic is the manifestation of
spontaneous convulsive seizures that develop from spe-
cific areas in the central nervous system. From a clinical
perspective, treatment to control seizures is restricted to
anti-epileptic drug therapy. A growing number of re-
ports have shown the therapeutic potential of stem cells
obtained from various sources, such as bone marrow,
brain, cord blood and skin, in the treatment of diseases* Correspondence: beatriz.longo@unifesp.br
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stated.affecting the central nervous system [1]. Bone marrow has
been suggested as an accessible source of multipotent
cells, and it has been used to treat patients with neuro-
logical diseases in a number of clinical trials [2-5]. It is be-
lieved that one of the major protective mechanisms of
bone marrow stem cells is a paracrine effect by secreting
substances with anti-inflammatory, anti-apoptotic, prolif-
erative and pro-angiogenic actions [6-8]. However, bone
marrow is also a source of inflammatory cells, which can
infiltrate and proliferate into the brain parenchyma in re-
sponse to alterations that may occur after epileptic sei-
zures [9-13]. The continuous traffic of inflammatory cells
into the cerebral tissue is accelerated after injury [14,15]
and is involved in cytokine response to seizures [16-18].
Thus, the inflammatory reaction induced by acute seizurel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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a critical point that was evaluated here.
Maximum electroconvulsive shock (MES) is a classic ex-
perimental model for the induction of single generalized
tonic-clonic seizure activity in rodents. MES mimics sei-
zures commonly found in drug-resistant epilepsy patients,
and it is the elected model for the primary screening of
new antiepileptic drugs [19,20]. The MES screening test
evaluates the effects of anticonvulsant drugs in preventing
the spread of convulsive activity throughout the neural tis-
sue, which is indicated by the abolishment of the hindlimb
tonic extensor component of seizure [21,22]. Interestingly,
the induction of MES has been implicated in alterations of
microglial expression patterns and blood levels of cyto-
kines, which indicates a commitment of inflammatory re-
sponses to the convulsive stimulus [23,24].
Based on these data, the focus of the current study
was to investigate the effects of bone marrow cell trans-
plantation on the behavioral and inflammatory responses
to acute generalized tonic-clonic seizures induced by
using the MES model. Because MES is the elected model
to test anticonvulsive compounds, we proposed the use
of MES to verify the ability of the transplanted bone
marrow cells to inhibit seizure spread in the same para-
digm as used in pharmacological screening tests.
Results
Behavioral seizure analysis
MES stimulus (65 mA; 60 Hz; 0.15 sec) was applied in
animals transplanted with bone marrow cells (MES-BM,
n = 37), saline (MES-S, n = 35) and bone marrow dead
cells (MES-DC, n = 12). Detailed analysis of the acute
seizures induced by the MES stimulus indicated a reduc-
tion in the number of animals that developed tonic sei-
zures with tonic hindlimb extension in the MES-BM
group compared with the MES-S group (Chi-Square p =
0.039; ANOVA one-way followed by Tukey’s test, p =
0.0270). In the MES-S group, 88% of the animals andFigure 1 Analysis of behavioral parameters of tonic seizures. Percenta
(seconds) of tonic seizures (B); and the animal mortality rates (percentage)
The frequency of animals and duration of tonic seizures were significantly
group (*p < 0.05, Chi-Square test and ANOVA one-way followed by Tukey’s83% in the MES-DC exhibited tonic seizures, whereas
only 64% of the MES-BM transplanted animals had tonic
seizures (Figure 1-A). Furthermore, the duration of tonic
seizures was significantly reduced in MES-BM animals
when compared to the MES-DC group (ANOVA one-way
followed by Tukey’s test p = 0.0016; Kruskal-Wallis p =
0.0026; Figure 1-B). No differences were detected between
MES-S and MES-DC. We also observed a lower mortality
rate among animals in the MES-BM group (12%) com-
pared with the MES-S and MES-DC groups that doubled
the value (25%), although this difference was not statisti-
cally significant (Figure 1-C).
Microglial analysis
The microglia expressing Iba1 was analyzed in naïve
medium- and BM-injected animals (CTRL), MES-S,
MES-BM groups in the neocortex (Cx), striatum (CPu),
hippocampus (Hp), substantia nigra (SN), superior col-
liculus (SC), and periaqueductal gray area (PAG). Naïve
bone marrow-injected animals composed, together with
medium-injected animals, the control group for the Iba1
quantification (CTRL). Differences between the groups
were detected for three main regions of interest, Cx, Hp
and SN based on evidence that these areas are involved
in motor activity [25] and electroconvulsive seizure sus-
ceptibility [26-28].
Qualitative analysis of Iba1 cells indicated that there
were morphological differences between cells in the
non-stimulated control (CTRL =medium and BM) and
the MES groups. In CTRL group, Iba1 cells displayed
typical resting microglia morphology, were densely
ramified with thin processes [29,30]. The Iba1 cells of
MES-S, MES-DC and MES-BM stimulated animals
displayed thicker and fewer ramifications of cell
processes compared to non-stimulated animals. This
morphology has been described as an intermediate stage
between resting and reactive microglia [31,32] (Figure 2,
A-D, inset a-d).ge (frequency) of animals presenting with tonic seizures (A); duration
(C) between the three stimulated groups MES-S, MES-BM and MES-DC.
different and indicated reduction in theses parameters for the MES-BM
test). In B, data represent the means ± SEM.
Figure 2 Photomicrographs showing representative sections of Iba1-stained cells in the hippocampus of the four groups, medium-
injected naïve CTRL (A), MES stimulates saline-injected (MES-S) (B), MES stimulated bone marrow-injected (MES-BM) (C), and MES
stimulated dead cell-injected (MES-DC) (D) animals. Note the different morphological changes of Iba1 cells in a control animal (a) that show
intense arborization of microglial cells compared with animals exposed to MES (S, BM and DC, respectively in b, c and d). Scale bars represent
100 μm (A-D) and 10 μm (a-d).
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animals in the MES groups showed a higher values of
Iba1 cells compared with CTRL (ANOVA one-way
followed by Tukey’s test, p < 0.0001). MES-BM group
showed a lower number of cells expressing Iba1 when
compared to MES-DC animals (Tukey’s test, p < 0.05;
Figure 3-A). In the Hp, Kruskal-Wallis followed by
Dunn’s test detected differences between MES-BM and
CTRL, and MES-BM and MES-DC (p = 0.0004), indicat-
ing that the number of Iba1 cells in MES-BM-treatedFigure 3 Quantification of microglia expressing Iba1 in four brain stru
MES-S, MES-BM and MES-DC animals: (A) cortex (Cx); (B) hippocampu
significant reduction in the number of Iba1 cells was detected in the Cx (A
CTRL group; #p < 0.05 versus MES-DC group; in B *p < 0.05 versus CTRL and
versus CTRL). ANOVA one-way followed by Tukey’s multiple comparison tes
the mean ± SEM.group was higher when compared to these groups
(p < 0.05; Figure 3-B). Differences were also found for
SN indicating a significant reduction in the number of
Iba1 cells of the animals in MES-BM compared to MES-S,
MES-DC and CTRL groups (ANOVA one-way followed
by Tukey’s test, p < 0.0001; Figure 3-C). Although MES-BM
showed lower values for quantification of positively-
stained Iba1 cells in the CPu, SC and PAG, no significant
difference was detected between the groups in these areas
(data are not shown for the SC and PAG).ctures of naïve medium- and bone marrow-injected CTRL,
s (Hp); (C) substantia nigra (SN); and (D) striatum (CPu). A
), Hp (B) and SN (C) for f the MES-BM group (In A *p < 0.05 versus
MES-DC groups; in C *p < 0.05 versus the three groups; #p < 0.05
t and Kruskal-Wallis, followed by Dunn’s test. Data are presented as
Ferrazoli et al. BMC Neuroscience 2013, 14:97 Page 4 of 8
http://www.biomedcentral.com/1471-2202/14/97Cytokine analysis
To investigate the mechanisms by which bone marrow
cell therapy resulted in a protection of tonic seizures, we
tested whether bone marrow cell transplantation modu-
lates the levels of IL-1, IL-6, IL-10 and TNF-α. Blood
samples drawn to quantify levels of cytokines indicated
that IL-6 levels were diminished in MES-BM group
compared to MES-DC (ANOVA one-way p = 0.0006,
followed by Tukey’s test, p < 0.05). Also, significant dif-
ference was detected when both experimental groups S
and BM was compared (Student’s t test p = 0.0298). Al-
though higher IL-6 levels were detected in both the
MES-S and MES-DC groups when compared to naïve
medium and BM-injected CTRL groups (p < 0.05; p <
0.01; Figure 4-A), no difference was found between
MES-BM and CTRL or BM groups.
In contrast, for IL-10 blood levels, we detected a
higher value for the MES-BM group compared to MES-
S, MES-DC and naïve CTRL and BM groups (ANOVA
one-way, followed by Tukey’s test p < 0.0001; t test MES-S
versus MES-BM p = 0.0148; Figure 4-B). The levels of
IL-1α, IL-1β and TNF-α did not differ significantly be-
tween the MES groups submitted to the different treat-
ments (S, DC or BM) or CTRL (data are not shown for
the IL-1α, IL-1β and TNF-α).
Correlation analyses were performed to assess the rela-
tion of the duration of tonic seizure with the number of
Iba1 cells and the blood levels of IL-6 and IL-10. Signifi-
cant positive correlations were noted between the tonic
duration and the number of Iba1 in the cortex (r = 0.9998;
p < 0.0001), and between tonic duration and IL-6
(r = 0.9167; p = 0.0165). The longer the tonic seizure the
more Iba1 cells counted in the cortex, and the higher
the IL-6 blood levels. The same was near to occur be-
tween the tonic duration and IL-10, with the difference
coming close to the significance threshold for a negativeFigure 4 Histograms depicting the blood levels of IL-6 (A) and IL-10 (
MES-BM and MES-DC animals. ANOVA one-way followed by Tukey’s mul
versus CTRL and BM; #p < 0.05 versus MES-DC; @p < 0.05 versus CTRL, BM an
represent means ± SEM.correlation (r = − 0.7594; p = 0.0799). No other significant
correlation was observed.
Discussion and conclusions
Our results indicate that bone marrow cells may alter the
convulsive threshold and also show anticonvulsant effects
by protecting transplanted animals from tonic seizures.
Bone marrow cells were tested under the same paradigm
as that employed in the pharmacologic screening of po-
tential antiepileptic drugs [21], using MES as a model to
evaluate the protective effect of the cells in vivo. As sug-
gested by Stable and Kupferberg [33], the ability of the
tested compound to inhibit MES-induced seizure spread
is indicated by abolition of the hindlimb tonic extensor
component of seizures. With this experimental design,
primary screening showed that bone marrow cells were
able not only to protect transplanted animals against the
tonic component, but also to reduce the duration of the
tonic phase of generalized seizures. These data are consist-
ent with previous findings in which authors observed a
protective effect of bone marrow cells transplanted in
already-epileptic animals [34].
As has been outlined before, bone marrow-derived
cells in the CNS contribute mainly for the generation of
microglia [14,35-40]. We reported previously that after
status epilepticus, the number of microglia originated
from bone marrow increases dramatically [12]. However,
here the temporal window between cell transplantation
and the electroshock stimulus was too short to have
allowed for migration of the cells into the brain paren-
chyma. Indeed, after the electroshock GFP+ cells were
not present in the parenchyma of animals transplanted
with bone marrow cells obtained from the transgenic
EGFP donor mice (data not shown). We speculate that
bone marrow transplanted cells might have a paracrine
action that influences the microglial activity, in areasB) of naïve CTRL medium- and BM-injected animals and, MES-S,
tiple comparison test indicates significant differences (in A *p < 0.05
d MES-BM groups; in B *p < 0.01 versus the four groups). Data
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the release of modulatory substances that could switch
off the tonic activity. As already described, microglia
have been observed to show morphological alterations
after electrical convulsive shock [23,24]. Jansson and
colleagues described a reduction of the density of pro-
cesses of microglia following electroconvulsive shock. In
a similar manner, we observed a clear reduction in the
ramification of resident microglia after the electrical
convulsive stimulation, regardless of the bone marrow
cell administration, indicative of an intermediate stage
between resting and reactive microglia [31,32].
As suggested by Browning and colleagues, generalized
seizures have distinct neuroanatomical substrates that
start and sustain the seizure activity [41]. After the elec-
troconvulsive shock, the reactive response of microglia
in the striatum and substantia nigra, areas strongly
connected and related to motor activity, is probably due
to the intense motor activity seen during the tonic seiz-
ure. Microglial expression was otherwise suppressed in
transplanted animals (MES-BM compared with MES-
DC) in SN (with a tendency in CPu) because the motor
activity related to tonic seizure was protected by bone
marrow cell transplantation. Although the tonic compo-
nent of seizure was protected in MES-BM animals, the
stimulated groups (MES-S, MES-DC and MES-BM)
presented clonic seizures, which may explain the ab-
sence of differences in these areas and consequently sug-
gest their responsiveness to the clonic seizure. In the
hippocampus, a structure that is susceptible to convul-
sive seizures [42,43], and that contains cells vulnerable
to electroshock [26-28], transplantation of bone marrow
cells in MES animals was able to raise the number of
microglial cells. Concerning these data, we speculated
whether the observed increase in Iba1 cells in the hippo-
campus was due to its role in generalized or focal
seizures and/or by a direct participation on persisting
clonic seizures. As proposed by Silverberg and co-
authors, inflammatory cells are specifically recruited to
damaged regions of brain associated with the focus of
seizure [44]. These authors suggested that in MES
seizures, currents may spread throughout the brain and
the intensity and/or duration of stimulus could alter
cytokine and chemokine production. It has been also de-
scribed that the number of Iba1cells was increased
around the mesenchymal bone marrow transplanted
cells in hippocampus of mice with Alzheimer’s disease
[45]. The transplantation per se accelerates the activation
of microglia, regardless of pathological condition. In our
case, the generalized seizures promoted by the MES
stimulation, together with the injection of BM cells, may
suggest that the higher numbers of hippocampal micro-
glia found in transplanted animals function as part of an
inflammatory response to seizure.As suggested by Jankowsky and Patterson [32], the onset
and duration of seizure are influenced by a variety of types
and levels of cytokines that, at the time of induction, may
compete to determine the behavioral outcome. Several
studies have reported elevated concentrations of IL-6 im-
mediately after seizure activity [46,47]. In our hands, the
trigger of MES convulsion induced an increase in IL-6
blood levels in both MES-S and MES-DC groups. How-
ever, these levels were decreased in animals transplanted
with bone marrow cells. The low levels of IL-6 detected in
MES-BM mice might be related the reduction of tonic
seizure in these animals, as suggested by Pearson’s correl-
ation. In concert with the decrease in IL-6 levels observed
in BM transplanted animals, blood levels of IL-10 were
higher in those animals, which may reduce susceptibility
to seizures induced by pro-inflammatory cytokines, al-
though it was not detected in correlation analysis. Our
data corroborate other findings that showed a reduction
in the pro-inflammatory cytokines and an increased in the
IL-10 of chronic epileptic rats treated with mouse bone
marrow cells [48]. Accordingly, other authors proposed
that IL-10 expression may be induced simultaneously with
pro-inflammatory cytokines in the brain following an in-
sult [49,50]. The beneficial or detrimental roles of the in-
nate immune response in the epileptic tissue, however,
still needs to be clarified [17]. To understand the relation-
ship between cytokine signaling and bone marrow cell
function in the epileptic brain, additional studies during
the chronic period of spontaneous seizures are required.
Taken together, these results suggest that transplanted
bone marrow cells exert protective effects by blocking
the tonic component of generalized seizures induced by
MES. Moreover, electroconvulsive seizures applied in
transplanted mice triggered acute responses altering the
pattern of microglia expression and blood levels of inter-
leukins. Additionally, we suggest that the anticonvulsive
potential of progenitor cells may be tested by the MES
model, as a primary screen, in the same paradigm as that
used for drug testing in pharmacological screening. In
spite of these promising results, several considerations
concerning the transplantation strategies, such as the
number of cells and the timing and route of administra-
tion should be elucidated. Further studies on the inflam-
matory response to acute seizures in the presence of
transplanted bone marrow cells could prove to be benefi-
cial, and may open broad and productive discussions on
mechanisms relevant to the pathophysiology of epilepsy.
Methods
All animals were housed in a pathogen-free facility and
maintained in accordance with the Guide for the Care
and Use of Laboratory Animals (National Research Coun-
cil). All protocols were approved by the Ethics Committee
of Universidade Federal de São Paulo (UNIFESP), process
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proval by the Comissão Nacional de Ética em Pesquisa
(CONEP).
Bone marrow cell extraction
Bone marrow cells were obtained from adult C57Bl/6-
donor mice (20–25 g) (JAX® Mice and Services, Bar
Harbor, Maine, USA) by flushing the femurs and tibiae
with sterile medium. The mononuclear cell fraction was
purified by centrifugation in a Ficoll-Paque gradient
(Stemcell Technologies Inc, Vancouver, Canada). The
cells were washed four times in Dulbecco’s Modified
Eagle Medium (DMEM, Gibco, Grand Island, NY, EUA),
counted and resuspended in sterile saline. Viability of
cells was determined by trypan blue (Gibco, Grand
Island, NY, EUA) dye exclusion test. Briefly, cells were
incubated with trypan blue dye for 1 min. White cells
was counted excluding blue positive cells in Neubauer
chamber, and the percent of viable cells was calculated.
Approximately 1 × 106 cells diluted in 200 μL or saline
were delivered to each recipient animal by intravenous
administration. Additionally to the saline (MES-S) and
bone marrow (MES-BM) groups, age-matched groups
were prepared by injecting similar volumes of bone mar-
row dead cells (MES-DC), obtained by repeated frost
and thaw cycles, as a control for the inflammatory
response, conditioned medium and cell toxicity; naïve
bone marrow alive cells (BM), and medium-injected
(CTRL) groups that were not seizure-induced by MES.
Maximum electroconvulsive shock (MES) induction
Thirty minutes after saline or cell administration, an
electrical stimulus (65 mA; 60 Hz; 0.15 sec duration)
was applied through a pair of corneal electrodes (AVS,
Solução Integrada, São Paulo-SP) to induce acute gener-
alized tonic-clonic seizure [19,20]. The criterion for the
occurrence of seizure activity was the tonic hindlimb ex-
tension response. The parameters used to estimate the
anticonvulsant activity of transplanted cells were the
protection against tonic hindlimb extension and the re-
duction in tonic seizure duration.
Immunohistochemistry
Two hours after the MES stimulus, mice were intraperi-
toneally anesthetized with thionembutal (200 mg/kg;
Cristália, Brazil) and transcardially perfused with phos-
phate buffered saline (PBS; 100 mM, pH 7.2), followed
by 4% paraformaldehyde (PFA) in PBS (w/v), 50–100 mL
over 10 minutes per animal. The brains were removed
and processed for immunohistochemistry on free-floating
brain slices. Coronal brain sections (30 μm thick) were
made between bregma 0.98 and bregma −3.28 mm,
targeting the areas of interest in forebrain and midbrain;
Cx, CPu, Hp, SC, SN, and PAG, according to thestereotaxic coordinates of the mouse brain atlas [51]. The
sections were selected (9 per animal) by targeting the
areas of interest (neocortex, striatum and hippocampus),
which were left free-floating in a multi-well plate. To stain
microglia, sections were incubated in polyclonal rabbit
anti-Iba1 primary antibody overnight (1:2000; Wako
Chemicals, Richmond, VA, USA), followed by a bio-
tinylated anti-rabbit secondary antibody for 2 h (1:600,
Sigma-Aldrich Corporation, St. Louis, EUA). After using
an ABC kit (Avidin/Biotinylated enzyme Complex
Vectastain Elite, Vector, Burlingame, CA, EUA) followed
by a DAB reaction (3,3’-Diaminobenzidine, Sigma-
Aldrich Corporation, St. Louis, EUA), the sections were
mounted on slides and sealed with coverslips. The slides
were examined using a light microscope (Nikon 80i),
and images were captured and digitized using the Nikon
ACT-1 v.2 system. In each section, nuclear profiles of
Iba1 cells were counted by an observer blinded to the
experimental condition of each animal. Cells stained for
Iba1 were counted under 20× magnification in 18 ran-
dom, non-overlapping fields of 0.02 mm2 per structure
of each animal.
Cytokine analysis
With the animals deeply anesthetized, approximately 1 mL
of blood was collected from abdominal aorta artery just be-
fore cardiac perfusion. Blood samples placed in 1.5 mL
tubes were allowed to clot for 2 h at room temperature be-
fore centrifugation for 15 min at 1000 × g. The sera were
collected, aliquoted and stored at −20°C. Analyte-specific
antibodies against IL-1α, IL-1β, IL-6, IL-10 and TNF-α
were pre-coated onto color-coded microparticles using the
MAP Fluorokine kit (R & D Systems, Inc.). Microparticles,
standards and samples were pipetted into wells and
incubated with antibodies specific for the analytes of inter-
est. After washing, streptavidin-phycoerythrin conjugate
(Streptavidin-PE) was added to each well. The micro-
particles were resuspended in buffer and quantified
using the Luminex analyzer (Luminex® 100/200 System,
Austin, USA).
Statistics
Statistical analyses were performed using Prism software
(version 288 5.01, GraphPad Software, San Diego, CA,
USA). Behavioral seizure, Iba1 cell and cytokine quantifi-
cations were analyzed with one-way analysis of variance
(ANOVA) followed by Tukey’s multiple comparison test,
and confirmed with Kruskall-Wallis followed by Dunn’s
multiple comparison test. Student’s t test was used to
compare two experimental groups. A significance level
of 5% was assumed.
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